Massive Bio empowers oncologists and hematologists with AI-driven clinical trial matching

Join our network to support patients and engage in high-level academic discussions.

Massive Bio has served over 160K+ onboarded patients,
19K+ number of trials patients have matched, and operates in 17 active markets.

Pharma Collaborations

1

Pharmaceutical & CRO Partnerships

Patient Advocacy Network

1

Patient Advocacy Collaborations

Industry Alliances

1

Business Partners

What to Expect
  • Online physician-only roundtable discussions
  • Peer-to-peer insight sharing
  • Moderated, topic-driven sessions
  • Honorarium provided for participation

Physician Roundtables

Physician Roundtables for Professional Exchange

Massive Bio hosts physician-only online roundtables for professional discussion and peer exchange. These sessions are designed to build long-term relationships with physicians interested in clinical trials.

Who This Is For:

  • Physicians affiliated treating cancer patients
  • Clinicians interested in professional dialogue and networking
  • Physicians open to ongoing roundtable events

Our Physician Process

physician flow horizontal

Oncology Trial Matching with Massive Bio

AI Driven Platform

Massive Bio offers free trial services, granting access to potential life-saving treatments. Join us to explore diverse treatment options and improve your prognosis and quality of life. Refer your patient to take advantage of their cutting-edge services.

dr arturo about

Oncology Trial Matching with Massive Bio

dr arturo about

AI Driven Platform

Massive Bio offers free trial services, granting access to potential life-saving treatments. Join us to explore diverse treatment options and improve your prognosis and quality of life. Refer your patient to take advantage of their cutting-edge services.

img@new map

Collaborating with more than 80 global partners

Massive Bio has provided health to more than 160K+ cancer patients in 17 countries across three continents. It collaborates with over 130+ global partners. In 2022, Massive Bio became part of the Precision Cancer Consortium (PCC), alongside major companies such as AstraZeneca, Bayer, Eli Lilly & Company, GSK, Johnson & Johnson/Janssen, Novartis and Roche.

Collaborating with more than 80 global partners

Massive Bio has provided health to more than 160K+ cancer patients in 17 countries across three continents. It collaborates with over 130+ global partners. In 2022, Massive Bio became part of the Precision Cancer Consortium (PCC), alongside major companies such as AstraZeneca, Bayer, Eli Lilly & Company, GSK, Johnson & Johnson/Janssen, Novartis and Roche.

img@new map

Our patient concierge services make it easier for physicians

Through Massive Bio, referred patients can take advantage of concierge services, making it easier for both physicians and patients to navigate the clinical trial enrollment process. Patient relations coordinators engage patients to answer their questions and understand their current condition, and oncology nurses help patients navigate the clinical trial enrolment process.

Our services include:

Support for you to finalize clinical trial selection

Facilitate communication between you, principal investigators and recruiting sites

Schedule a screening site visit for your patient

Resolve any logistics and financial issues during screening process

Follow up patients progress post enrolment

Start a Professional Collaboration

Select the option that aligns with your role. Our team will follow up accordingly.

Frequently Asked Questions

Clinical trials are research studies that involve people and test new ways to prevent, detect, diagnose, or treat diseases like cancer. Participating in clinical trials can give patients access to cutting-edge solutions.

Clinical trials have specific eligibility criteria that may include the type and stage of cancer, the patient’s overall health, and previous options received. Your healthcare provider or a clinical trial coordinator can help determine if you qualify.

Clinical trials are closely monitored to ensure participant safety. However, like any medical options, they carry risks, which are thoroughly explained to participants before they enroll.

o enroll in clinical trial, a patient must meet highly specific criteria that’s established by the researchers who are conducting the investigation. That includes detailed information about type of cancer, treatment history, response to treatment, and other data that is collected in medical records.

Massive Bio provides its services to the patients and their doctors at no cost—you won’t have to pay anything to receive a clinical-research matching report. There are no hidden costs involved.

Massive Bio strictly adheres to all HIPAA guidelines and international regulations focused on maintaining data privacy. We take extra measures to secure your personal information, ensuring it is protected beyond the mandatory requirements.